Clonal cytopenia of undetermined significance (CCUS)
Clinical trials for Clonal cytopenia of undetermined significance (CCUS) explained in plain language.
Never miss a new study
Get alerted when new Clonal cytopenia of undetermined significance (CCUS) trials appear
Sign up with your email to follow new studies for Clonal cytopenia of undetermined significance (CCUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug turn the tide on Hard-to-Treat blood conditions?
Disease control Not yet recruitingThis trial is testing an experimental drug called REGN17235 in people with two related blood conditions: clonal cytopenia of undetermined significance (CCUS) and low-risk myelodysplastic syndrome (MDS), both linked to a specific genetic change called an SF3B1 mutation. The main g…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE (CCUS)
Phase 1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can hidden blood mutations ignite heart disease?
Knowledge-focused Not yet recruitingThis study investigates clonal hematopoiesis, an age-related condition where blood stem cells acquire mutations, and how it triggers inflammation linked to heart disease. Researchers will compare immune cells from healthy people, those with high-risk mutations, and patients with …
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE (CCUS)
Sponsor: VASCage GmbH • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC